PortfoliosLab logoPortfoliosLab logo
NVOX vs. NVO
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

NVOX vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Defiance Daily Target 2X Long NVO ETF (NVOX) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

NVOX vs. NVO - Yearly Performance Comparison


2026 (YTD)20252024
NVOX
Defiance Daily Target 2X Long NVO ETF
-54.23%-76.65%-41.92%
NVO
Novo Nordisk A/S
-25.80%-39.22%-21.23%

Returns By Period

In the year-to-date period, NVOX achieves a -54.23% return, which is significantly lower than NVO's -25.80% return.


NVOX

1D
-2.05%
1M
-3.93%
YTD
-54.23%
6M
-68.69%
1Y
-81.87%
3Y*
5Y*
10Y*

NVO

1D
-0.73%
1M
-0.01%
YTD
-25.80%
6M
-36.19%
1Y
-43.88%
3Y*
-20.88%
5Y*
3.69%
10Y*
5.04%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NVOX vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVOX
NVOX Risk / Return Rank: 11
Overall Rank
NVOX Sharpe Ratio Rank: 22
Sharpe Ratio Rank
NVOX Sortino Ratio Rank: 11
Sortino Ratio Rank
NVOX Omega Ratio Rank: 11
Omega Ratio Rank
NVOX Calmar Ratio Rank: 00
Calmar Ratio Rank
NVOX Martin Ratio Rank: 11
Martin Ratio Rank

NVO
NVO Risk / Return Rank: 1010
Overall Rank
NVO Sharpe Ratio Rank: 88
Sharpe Ratio Rank
NVO Sortino Ratio Rank: 1111
Sortino Ratio Rank
NVO Omega Ratio Rank: 1010
Omega Ratio Rank
NVO Calmar Ratio Rank: 1111
Calmar Ratio Rank
NVO Martin Ratio Rank: 1111
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NVOX vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Defiance Daily Target 2X Long NVO ETF (NVOX) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NVOXNVODifference

Sharpe ratio

Return per unit of total volatility

-0.76

-0.81

+0.05

Sortino ratio

Return per unit of downside risk

-1.24

-0.99

-0.24

Omega ratio

Gain probability vs. loss probability

0.83

0.86

-0.03

Calmar ratio

Return relative to maximum drawdown

-0.95

-0.82

-0.13

Martin ratio

Return relative to average drawdown

-1.42

-1.41

-0.01

NVOX vs. NVO - Sharpe Ratio Comparison

The current NVOX Sharpe Ratio is -0.76, which is comparable to the NVO Sharpe Ratio of -0.81. The chart below compares the historical Sharpe Ratios of NVOX and NVO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


NVOXNVODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.76

-0.81

+0.05

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.10

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.16

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.82

0.46

-1.28

Correlation

The correlation between NVOX and NVO is 1.00, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


Dividends

NVOX vs. NVO - Dividend Comparison

NVOX has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 4.94%.


TTM20252024202320222021202020192018201720162015
NVOX
Defiance Daily Target 2X Long NVO ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVO
Novo Nordisk A/S
4.94%3.31%1.68%1.00%1.20%1.35%1.87%2.14%1.45%1.52%2.87%0.92%

Drawdowns

NVOX vs. NVO - Drawdown Comparison

The maximum NVOX drawdown since its inception was -94.50%, which is greater than NVO's maximum drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for NVOX and NVO.


Loading graphics...

Drawdown Indicators


NVOXNVODifference

Max Drawdown

Largest peak-to-trough decline

-94.50%

-74.70%

-19.80%

Max Drawdown (1Y)

Largest decline over 1 year

-87.05%

-55.03%

-32.02%

Max Drawdown (5Y)

Largest decline over 5 years

-74.70%

Max Drawdown (10Y)

Largest decline over 10 years

-74.70%

Current Drawdown

Current decline from peak

-94.06%

-73.49%

-20.57%

Average Drawdown

Average peak-to-trough decline

-72.00%

-17.56%

-54.44%

Ulcer Index

Depth and duration of drawdowns from previous peaks

58.03%

31.83%

+26.20%

Volatility

NVOX vs. NVO - Volatility Comparison

Defiance Daily Target 2X Long NVO ETF (NVOX) has a higher volatility of 18.87% compared to Novo Nordisk A/S (NVO) at 9.39%. This indicates that NVOX's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


NVOXNVODifference

Volatility (1M)

Calculated over the trailing 1-month period

18.87%

9.39%

+9.48%

Volatility (6M)

Calculated over the trailing 6-month period

80.41%

38.79%

+41.62%

Volatility (1Y)

Calculated over the trailing 1-year period

107.99%

54.16%

+53.83%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

107.21%

37.82%

+69.39%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

107.21%

32.28%

+74.93%